Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Teratogenicity of lamotrigine.

Shor S, Koren G, Nulman I.

Can Fam Physician. 2007 Jun;53(6):1007-9.

2.

Preliminary results on pregnancy outcomes in women using lamotrigine.

Tennis P, Eldridge RR; International Lamotrigine Pregnancy Registry Scientific Advisory Committee.

Epilepsia. 2002 Oct;43(10):1161-7.

3.

Epilepsy and pregnancy: lamotrigine as main drug used.

Sabers A, Dam M, A-Rogvi-Hansen B, Boas J, Sidenius P, Laue Friis M, Alving J, Dahl M, Ankerhus J, Mouritzen Dam A.

Acta Neurol Scand. 2004 Jan;109(1):9-13.

PMID:
14653845
4.

Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy.

Holmes LB, Baldwin EJ, Smith CR, Habecker E, Glassman L, Wong SL, Wyszynski DF.

Neurology. 2008 May 27;70(22 Pt 2):2152-8. doi: 10.1212/01.wnl.0000304343.45104.d6. Epub 2008 Apr 30. Erratum in: Neurology. 2009 Apr 21;72(16):1449.

PMID:
18448870
5.

[Epilepsy and pregnancy].

Dominguez M, Díaz Obregón MC, Bhathal H, Santiago R.

Rev Neurol. 2001 Dec 16-31;33(12):1179-85. Review. Spanish.

6.

Newer anticonvulsants: lamotrigine, topiramate and gabapentin.

Holmes LB, Hernandez-Diaz S.

Birth Defects Res A Clin Mol Teratol. 2012 Aug;94(8):599-606. doi: 10.1002/bdra.23028. Epub 2012 Jun 22.

PMID:
22730257
7.

Lamotrigine in pregnancy: safety profile and the risk of malformations.

Prakash, Prabhu LV, Nasar MA, Rai R, Madhyastha S, Singh G.

Singapore Med J. 2007 Oct;48(10):880-3. Review.

8.

Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F; EURAP Study Group.

Neurology. 2015 Sep 8;85(10):866-72. doi: 10.1212/WNL.0000000000001772. Epub 2015 Jun 17.

PMID:
26085607
9.

Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.

Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S.

Arch Neurol. 2011 Oct;68(10):1275-81. doi: 10.1001/archneurol.2011.133. Epub 2011 Jun 13.

PMID:
21670385
10.

Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?

Dolk H, Jentink J, Loane M, Morris J, de Jong-van den Berg LT; EUROCAT Antiepileptic Drug Working Group.

Neurology. 2008 Sep 2;71(10):714-22. doi: 10.1212/01.wnl.0000316194.98475.d8. Epub 2008 Jul 23.

PMID:
18650491
11.

Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies.

Dolk H, Wang H, Loane M, Morris J, Garne E, Addor MC, Arriola L, Bakker M, Barisic I, Doray B, Gatt M, Kallen K, Khoshnood B, Klungsoyr K, Lahesmaa-Korpinen AM, Latos-Bielenska A, Mejnartowicz JP, Nelen V, Neville A, O'Mahony M, Pierini A, Rißmann A, Tucker D, Wellesley D, Wiesel A, de Jong-van den Berg LT.

Neurology. 2016 May 3;86(18):1716-25. doi: 10.1212/WNL.0000000000002540. Epub 2016 Apr 6.

12.

American Academy of Pediatrics Committee on Drugs: anticonvulsants and pregnancy.

[No authors listed]

Pediatrics. 1979 Feb;63(2):331-3.

PMID:
440824
13.
14.

Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register.

Vajda FJ, Graham JE, Hitchcock AA, O'Brien TJ, Lander CM, Eadie MJ.

Seizure. 2010 Nov;19(9):558-61. doi: 10.1016/j.seizure.2010.07.019. Epub 2010 Aug 24.

15.

Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA, Wiebe S, Thurman D, Koppel BS, Kaplan PW, Robinson JN, Hopp J, Ting TY, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Hirtz D, Le Guen C; American Academy of Neurology; American Epilepsy Society.

Epilepsia. 2009 May;50(5):1237-46. Review.

PMID:
19507301
16.

Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study.

de Haan GJ, Edelbroek P, Segers J, Engelsman M, Lindhout D, Dévilé-Notschaele M, Augustijn P.

Neurology. 2004 Aug 10;63(3):571-3.

PMID:
15304599
17.

Valproic acid and lamotrigine treatment during pregnancy. The risk of chromosomal abnormality.

Ozkinay F, Cogulu O, Gunduz C, Yilmaz D, Kultursay N.

Mutat Res. 2003 Jan 10;534(1-2):197-9.

PMID:
12504768
18.

Seizure frequency in pregnant women treated with lamotrigine monotherapy.

Sabers A, Petrenaite V.

Epilepsia. 2009 Sep;50(9):2163-6. doi: 10.1111/j.1528-1167.2009.02166.x. Epub 2009 Jun 1.

19.

Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.

Tomson T, Perucca E, Battino D.

Epilepsia. 2004 Oct;45(10):1171-5.

20.

Comparative safety of antiepileptic drugs during pregnancy.

Hernández-Díaz S, Smith CR, Shen A, Mittendorf R, Hauser WA, Yerby M, Holmes LB; North American AED Pregnancy Registry; North American AED Pregnancy Registry.

Neurology. 2012 May 22;78(21):1692-9. doi: 10.1212/WNL.0b013e3182574f39. Epub 2012 May 2.

PMID:
22551726

Supplemental Content

Support Center